Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Fujimura

Showing results (31-40 of 283) with videos related to

Pageof 29
Sort By:
Dermatologic Therapy|April 29, 2021
Phosphor-signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumabErika Tamabuchi, Taku Fujimura, Chunbing Lyu, et al.
Case Reports in Dermatology|June 17, 2011
Rapid Growth of Dermatofibrosarcoma Protuberans Associated with Bilateral Adrenalectomy for Cushing's SyndromeSadanori Furudate, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|April 8, 2009
Papuloerythroderma associated with monoclonal gammopathy of undetermined significanceTaku Fujimura, Ryuhei Okuyama, Eisaku Ogawa, et al.
Case Reports in Dermatology|November 24, 2011
Myeloid sarcoma in a one-month-old infantChihiro Wakusawa, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|August 30, 2020
Severe eczematoid and lichenoid eruption with full-thickness epidermal necrosis developing from metastatic urothelial cancer treated with enfortumab vedotinRui Sasaki, Taku Fujimura, Chunbing Lyu, et al.
Dermatologic Therapy|September 20, 2020
Multiple angiolymphoid hyperplasia with eosinophilia on the right arm showing unusual presentationErika Tamabuchi, Taku Fujimura, Chinbing Lyu, et al.
Case Reports in Dermatology|April 30, 2013
Profiles of cytotoxic T lymphocytes in cutaneous lymphoid hyperplasia of the faceSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|June 29, 2023
Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate CancerMana Sekine, Hitoshi Terui, Taku Fujimura, et al.
Frontiers in Oncology|December 16, 2021
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma PatientsKentaro Ohuchi, Yumi Kambayashi, Takanori Hidaka, et al.
Frontiers in Medicine|August 17, 2019
Biomarkers for Predicting Efficacies of Anti-PD1 AntibodiesYumi Kambayashi, Taku Fujimura, Takanori Hidaka, et al.
Pageof 29

Showing results (31-40 of 283) with videos related to

Sort By:
Pageof 29
Dermatologic Therapy|April 29, 2021
Phosphor-signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumabErika Tamabuchi, Taku Fujimura, Chunbing Lyu, et al.
Case Reports in Dermatology|June 17, 2011
Rapid Growth of Dermatofibrosarcoma Protuberans Associated with Bilateral Adrenalectomy for Cushing's SyndromeSadanori Furudate, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|April 8, 2009
Papuloerythroderma associated with monoclonal gammopathy of undetermined significanceTaku Fujimura, Ryuhei Okuyama, Eisaku Ogawa, et al.
Case Reports in Dermatology|November 24, 2011
Myeloid sarcoma in a one-month-old infantChihiro Wakusawa, Taku Fujimura, Akira Hashimoto, et al.
The Journal of Dermatology|August 30, 2020
Severe eczematoid and lichenoid eruption with full-thickness epidermal necrosis developing from metastatic urothelial cancer treated with enfortumab vedotinRui Sasaki, Taku Fujimura, Chunbing Lyu, et al.
Dermatologic Therapy|September 20, 2020
Multiple angiolymphoid hyperplasia with eosinophilia on the right arm showing unusual presentationErika Tamabuchi, Taku Fujimura, Chinbing Lyu, et al.
Case Reports in Dermatology|April 30, 2013
Profiles of cytotoxic T lymphocytes in cutaneous lymphoid hyperplasia of the faceSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|June 29, 2023
Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate CancerMana Sekine, Hitoshi Terui, Taku Fujimura, et al.
Frontiers in Oncology|December 16, 2021
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma PatientsKentaro Ohuchi, Yumi Kambayashi, Takanori Hidaka, et al.
Frontiers in Medicine|August 17, 2019
Biomarkers for Predicting Efficacies of Anti-PD1 AntibodiesYumi Kambayashi, Taku Fujimura, Takanori Hidaka, et al.
Pageof 29